Skip to main content
Just in

Perth cannabis company in $33m deal

Just in

Bookmark

Save articles for future reference.

WA's medicinal cannabis industry has notched another win for the week, with Zelira Therapeutics attaining $33 million in non-dilutive funding for its cannabis-based autism treatment.

X

To read our articles you will need to either login or subscribe.